Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00107757 · ClinicalTrials.gov registry record · Phase 3
Seasonal Allergic Rhinitis In Pediatric Subjects
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 576
- Enrollment target
NCT00107757 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 576 participants.
The verdict
NCT00107757, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 576 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.
Interventions
- DRUG GW685698X
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 576 participants |
| Start Date | 2005-03 |
| Est. Completion | 2005-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00107757
The ClinicalTrials.gov registry entry for NCT00107757 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 576 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GW685698X is the first listed.
NCT00107757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00107757 about?
NCT00107757 is a clinical study titled "Seasonal Allergic Rhinitis In Pediatric Subjects". The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.
What is the current status of trial NCT00107757?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 576 participants. The study started on 2005-03. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00107757?
The interventions under investigation include: GW685698X (DRUG).
Who is sponsoring clinical trial NCT00107757?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.